Alimentary Tract| Volume 53, ISSUE 7, P841-845, July 2021

Download started.


A novel gene associated with small bowel bleeding in patients taking low-dose aspirin


      We have previously revealed the clinical factors and genetic polymorphisms associated with gastrointestinal mucosal injury and bleeding, induced by low-dose aspirin (LDA). After performing genome-wide analysis of single nucleotide polymorphisms (SNPs) using the Drug Metabolizing Enzymes and Transporters (DMET) system among drug metabolism and transporter genes, certain SNPs were found to increase the risk for LDA-induced small bowel bleeding. The aim of this study was to identify the SNPs involved in LDA-induced small bowel bleeding.

      Subjects and methods

      Subjects were patients taking LDA, with small bowel bleeding diagnosed using capsule endoscopy. We investigated the clinical characteristics and the previously identified SNPs, that were examined by the DNA direct sequence method.


      56 patients with bleeding and 410 controls taking LDA were enrolled. The risk factors associated with small bowel bleeding included smoking, cerebrovascular diseases, chronic renal failure, non-steroidal anti-inflammatory drug (NSAID) or anticoagulants combination, and two SNPs (CYP4F11 20043G>A (D446N) rs1060463, GSTP1 313A>G rs1695). After propensity score matching, GSTP1 rs1695 was significantly associated with small bowel bleeding.


      The GSTP1 SNP may be a predictive marker for small bowel bleeding among patients taking LDA.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gerson L.B.
        • Fidler J.L.
        • Cave D.R.
        • et al.
        ACG clinical guideline: diagnosis and management of small bowel bleeding.
        Am J Gastroenterol. 2015; 110 (quiz 88): 1265-1287
        • Carey E.J.
        • Leighton J.A.
        • Heigh R.I.
        • et al.
        A single-center experience of 260 consecutive patients undergoing capsule endoscopy for obscure gastrointestinal bleeding.
        Am J Gastroenterol. 2007; 102: 89-95
        • Raju G.S.
        • Gerson L.
        • Das A.
        • et al.
        American Gastroenterological Association (AGA) institute medical position statement on obscure gastrointestinal bleeding.
        Gastroenterology. 2007; 133: 1694-1696
        • Otani K.
        • Watanabe T.
        • Shimada S.
        • et al.
        Clinical utility of capsule endoscopy and double-balloon enteroscopy in the management of obscure gastrointestinal bleeding.
        Digestion. 2018; 97: 52-58
        • Shiotani A.
        • Kamada T.
        • Haruma K.
        Low-dose aspirin-induced gastrointestinal diseases: past, present, and future.
        J Gastroenterol. 2008; 43: 581-588
        • Tanaka S.
        • Mitsui K.
        • Yamada Y.
        • et al.
        Diagnostic yield of double-balloon endoscopy in patients with obscure GI bleeding.
        Gastrointest Endosc. 2008; 68: 683-691
        • Matsumoto T.
        • Kudo T.
        • Esaki M.
        • et al.
        Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study.
        Scand J Gastroenterol. 2008; 43: 490-496
        • Graham D.Y.
        • Opekun A.R.
        • Willingham F.F.
        • et al.
        Visible small-intestinal mucosal injury in chronic NSAID users.
        Clin Gastroenterol Hepatol. 2005; 3: 55-59
        • Maiden L.
        • Thjodleifsson B.
        • Theodors A.
        • et al.
        A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
        Gastroenterology. 2005; 128: 1172-1178
        • Watanabe T.
        • Sugimori S.
        • Kameda N.
        • et al.
        Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study.
        Clin Gastroenterol Hepatol. 2008; 6: 1279-1282
        • Smecuol E.
        • Pinto Sanchez M.I.
        • Suarez A.
        • et al.
        Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment.
        Clin Gastroenterol Hepatol. 2009; 7: 524-529
        • Endo H.
        • Hosono K.
        • Inamori M.
        • et al.
        Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy.
        J Gastroenterol. 2009; 44: 544-549
        • Endo H.
        • Hosono K.
        • Inamori M.
        • et al.
        Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.
        Digestion. 2009; 79: 44-51
        • Hara A.
        • Ota K.
        • Takeuchi T.
        • et al.
        Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study.
        J Clin Biochem Nutr. 2018; 63: 224-229
        • Handa O.
        • Naito Y.
        • Fukui A.
        • et al.
        The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium.
        J Clin Biochem Nutr. 2014; 54: 2-6
        • Watanabe T.
        • Higuchi K.
        • Kobata A.
        • et al.
        Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent.
        Gut. 2008; 57: 181-187
        • Reuter B.K.
        • Davies N.M.
        • Wallace J.L.
        Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.
        Gastroenterology. 1997; 112: 109-117
        • Somasundaram S.
        • Rafi S.
        • Hayllar J.
        • et al.
        Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
        Gut. 1997; 41: 344-353
        • Anthony A.
        • Pounder R.E.
        • Dhillon A.P.
        • et al.
        Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin.
        Gut. 1997; 41: 763-770
        • van Oijen M.G.
        • Laheij R.J.
        • Koetsier M.
        • et al.
        Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage.
        Dig Dis Sci. 2006; 51: 2348-2352
        • Shiotani A.
        • Sakakibara T.
        • Yamanaka Y.
        • et al.
        Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin.
        J Gastroenterol. 2009; 44: 126-131
        • Shiotani A.
        • Sakakibara T.
        • Nomura M.
        • et al.
        Aspirin-induced peptic ulcer and genetic polymorphisms.
        J Gastroenterol Hepatol. 2010; 25: S31-S34
        • Shiotani A.
        • Nishi R.
        • Yamanaka Y.
        • et al.
        Renin-angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes' polymorphism.
        Dig Dis Sci. 2011; 56: 465-471
        • Shiotani A.
        • Murao T.
        • Sakakibara T.
        • et al.
        Association of SLCO1B1 1b with peptic ulcer amongst Japanese patients taking low-dose aspirin.
        Dig Liver Dis. 2012; 44: 201-205
        • Shiotani A.
        • Murao T.
        • Fujita Y.
        • et al.
        Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding.
        PLoS ONE. 2013; 8: e84244
        • Pilotto A.
        • Seripa D.
        • Franceschi M.
        • et al.
        Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
        Gastroenterology. 2007; 133: 465-471
        • Ishihara M.
        • Ohmiya N.
        • Nakamura M.
        • et al.
        Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.
        Aliment Pharmacol Ther. 2014; 40: 538-547
        • D'Agostino R.B.
        Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.
        Stat Med. 1998; 17: 2265-2281
        • Henderson C.J.
        • Wolf C.R.
        Disruption of the glutathione transferase pi class genes.
        Methods Enzym. 2005; 401: 116-135
        • Tew K.D.
        Glutathione-associated enzymes in anticancer drug resistance.
        Cancer Res. 1994; 54: 4313-4320
        • Adler V.
        • Yin Z.
        • Fuchs S.Y.
        • et al.
        Regulation of JNK signaling by GSTp.
        EMBO J. 1999; 18: 1321-1334
        • Ramirez-Alcantara V.
        • LoGuidice A.
        • Boelsterli U.A.
        Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy.
        Am J Physiol Gastrointest Liver Physiol. 2009; 297: G990-G998
        • Xue B.
        • Wu Y.
        • Yin Z.
        • et al.
        Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells.
        FEBS Lett. 2005; 579: 4081-4087
        • Omatsu T.
        • Naito Y.
        • Handa O.
        • et al.
        Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells.
        J Gastroenterol. 2009; 44: 30-34
        • Omatsu T.
        • Naito Y.
        • Handa O.
        • et al.
        Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury.
        J Gastroenterol. 2010; 45: 692-702
        • Handa O.
        • Majima A.
        • Onozawa Y.
        • et al.
        The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury.
        Free Radic Res. 2014; 48: 1095-1099
        • Fukui A.
        • Naito Y.
        • Handa O.
        • et al.
        Acetyl salicylic acid induces damage to intestinal epithelial cells by oxidation-related modifications of ZO-1.
        Am J Physiol Gastrointest Liver Physiol. 2012; 303: G927-G936
        • Simic T.
        • Savic-Radojevic A.
        • Pljesa-Ercegovac M.
        • et al.
        Glutathione S-transferases in kidney and urinary bladder tumors.
        Nat Rev Urol. 2009; 6: 281-289
        • Simeunovic D.
        • Odanovic N.
        • Pljesa-Ercegovac M.
        • et al.
        Glutathione transferase P1 polymorphism might be a risk determinant in heart failure.
        Dis Markers. 2019; 20196984845
        • Andrews F.J.
        • Malcontenti-Wilson C.
        • O'Brien P.E
        Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa.
        Am J Physiol. 1994; 266: G657-G664
        • Delaney J.A.
        • Opatrny L.
        • Brophy J.M.
        • et al.
        Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
        CMAJ. 2007; 177: 347-351
        • Wallace J.L.
        • Syer S.
        • Denou E.
        • et al.
        Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
        Gastroenterology. 2011; 141 (22.e1-5): 1314-1322
        • Endo H.
        • Sakai E.
        • Taniguchi L.
        • et al.
        Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry.
        Gastrointest Endosc. 2014; 80: 826-834
        • Watanabe T.
        • Tanigawa T.
        • Nadatani Y.
        • et al.
        Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage.
        Dig Liver Dis. 2013; 45: 390-395
        • Yamada A.
        • Niikura R.
        • Maki K.
        • et al.
        Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury: a propensity-matched analysis.
        PLoS ONE. 2017; 12e0182586